SG HealthCare Statistics
Total Valuation
SG HealthCare has a market cap or net worth of KRW 35.41 billion. The enterprise value is 39.77 billion.
Market Cap | 35.41B |
Enterprise Value | 39.77B |
Important Dates
The last earnings date was Friday, August 29, 2025.
Earnings Date | Aug 29, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SG HealthCare has 10.98 million shares outstanding. The number of shares has increased by 11.33% in one year.
Current Share Class | 10.98M |
Shares Outstanding | 10.98M |
Shares Change (YoY) | +11.33% |
Shares Change (QoQ) | +0.91% |
Owned by Insiders (%) | 31.19% |
Owned by Institutions (%) | 8.29% |
Float | 7.29M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.61 |
PB Ratio | 1.60 |
P/TBV Ratio | 1.66 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -7.48 |
EV / Sales | 2.93 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -5.79 |
Financial Position
The company has a current ratio of 2.15, with a Debt / Equity ratio of 0.30.
Current Ratio | 2.15 |
Quick Ratio | 1.05 |
Debt / Equity | 0.30 |
Debt / EBITDA | n/a |
Debt / FCF | -0.96 |
Interest Coverage | -5.49 |
Financial Efficiency
Return on equity (ROE) is -28.94% and return on invested capital (ROIC) is -5.67%.
Return on Equity (ROE) | -28.94% |
Return on Assets (ROA) | -5.13% |
Return on Invested Capital (ROIC) | -5.67% |
Return on Capital Employed (ROCE) | -10.71% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.46 |
Inventory Turnover | 1.53 |
Taxes
Income Tax | -537.28M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -49.42% in the last 52 weeks. The beta is 0.02, so SG HealthCare's price volatility has been lower than the market average.
Beta (5Y) | 0.02 |
52-Week Price Change | -49.42% |
50-Day Moving Average | 3,164.90 |
200-Day Moving Average | 3,564.10 |
Relative Strength Index (RSI) | 56.35 |
Average Volume (20 Days) | 31,126 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SG HealthCare had revenue of KRW 13.55 billion and -5.32 billion in losses. Loss per share was -527.43.
Revenue | 13.55B |
Gross Profit | 3.38B |
Operating Income | -2.42B |
Pretax Income | -5.85B |
Net Income | -5.32B |
EBITDA | -1.88B |
EBIT | -2.42B |
Loss Per Share | -527.43 |
Balance Sheet
The company has 2.35 billion in cash and 6.62 billion in debt, giving a net cash position of -4.27 billion or -389.22 per share.
Cash & Cash Equivalents | 2.35B |
Total Debt | 6.62B |
Net Cash | -4.27B |
Net Cash Per Share | -389.22 |
Equity (Book Value) | 22.06B |
Book Value Per Share | 2,001.77 |
Working Capital | 10.04B |
Cash Flow
In the last 12 months, operating cash flow was -2.05 billion and capital expenditures -4.82 billion, giving a free cash flow of -6.87 billion.
Operating Cash Flow | -2.05B |
Capital Expenditures | -4.82B |
Free Cash Flow | -6.87B |
FCF Per Share | -625.37 |
Margins
Gross margin is 24.93%, with operating and profit margins of -17.85% and -39.26%.
Gross Margin | 24.93% |
Operating Margin | -17.85% |
Pretax Margin | -43.14% |
Profit Margin | -39.26% |
EBITDA Margin | -13.84% |
EBIT Margin | -17.85% |
FCF Margin | n/a |
Dividends & Yields
SG HealthCare does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -11.33% |
Shareholder Yield | n/a |
Earnings Yield | -15.02% |
FCF Yield | -19.39% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on December 4, 2024. It was a reverse split with a ratio of 0.3285691.
Last Split Date | Dec 4, 2024 |
Split Type | Reverse |
Split Ratio | 0.3285691 |
Scores
SG HealthCare has an Altman Z-Score of 2.23 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.23 |
Piotroski F-Score | 2 |